AIM |
Absence in melanoma 2 |
ALRs |
Absence in melanoma 2-like receptors |
AP |
Acute pancreatitis |
ASC |
Caspase recruitment domain |
CAPS |
Cryopyrin-associated periodic syndrome |
CARD |
Caspase activation and recruitment domain |
CARS |
Compensatory anti-inflammatory response syndrome |
CLRs |
C-type lectin receptors |
COX-2 |
Cyclo-oxygenase-2 |
DAMPs |
Damage-Associated Molecular Patterns |
GSDM-D |
Gasdermin-D |
HMGB1 |
High mobility group box 1 |
IL |
Interleukin |
IL1R |
Interleukin 1 receptor |
IRAK |
IL1R-associated kinase |
IRF |
Interferon regulatory factor |
LPS |
Lipopolysaccharide |
MAPK |
Mitogen-activated protein kinase |
MyD88 |
Myeloid differentiation primary response 88 |
NATCH |
Nucleotide-binding and oligomerization domain |
NF-κB |
Nuclear factor-kappa B |
NLRP3 |
NLR pyrin domain containing protein 3 |
NOD1 |
NLR nucleotide-binding oligomerization domain-containing protein 1 |
Nrf2 |
Nuclear factor erythrocyte-2 associated factor 2 |
NSAIDS |
Non-steroidal anti-inflammatory drugs |
PAMPs |
Pathogen-Associated Molecular Patterns |
PRR |
Pattern recognition receptors |
PYD |
Pyrin domain |
RAGE |
Receptor for advanced glycation end-products |
RLRs |
Retinoic acid-inducible gene (RIG)-I-like receptors |
ROS |
Reactive oxygen species |
SIRS |
Systemic inflammatory response syndrome |
TLR |
Toll-like receptor |
TNFα |
Tumor necrosis factor alpha |
TRAF |
Tumor necrosis factor receptor-activated factor |
TRIF |
TIR-domain-containing adaptor molecule inducing interferon-beta |